نتائج البحث

非诺贝特干预超氧化物歧化酶 2 转基因 C57BL/6J 小鼠的神经保护机制.

• Authors : 马江磊¹; 张慧杰²; 张晨芳³

• Source: Chinese Journal of Tissue Engineering Research / Zhongguo Zuzhi Gongcheng Yanjiu. 10/8/2024, Vol. 28 Issue 28, p4547-4552. 6p.

تفاصيل العنوان

Beneficial effects of fenofibrate in pulmonary hypertension in rats.

• Authors : Galhotra P; Department of Pharmacology, All India Institute of Medical Sciences (AIIMS), Room No. 4017, Ansari Nagar, New Delhi, 110029, India.; Prabhakar P

Subjects: Fenofibrate/Fenofibrate/Fenofibrate/*pharmacology ; Hypertension, Pulmonary/Hypertension, Pulmonary/Hypertension, Pulmonary/*drug therapy ; Inflammation/Inflammation/Inflammation/*drug therapy

• Source: Molecular and cellular biochemistry [Mol Cell Biochem] 2018 Dec; Vol. 449 (1-2), pp. 185-194. Date of Electronic Publication: 2018 May 14.Publisher: Springer Country of Publication: Netherlands NLM ID: 0364456 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Role of fenofibrate in multiple sclerosis

• Authors : Ahmad A. Abulaban; Hayder M. Al-kuraishy; Ali I. Al-Gareeb

Subjects: Multiple sclerosis; Demyelination; Oxidative stress

• Source: European Journal of Medical Research, Vol 29, Iss 1, Pp 1-13 (2024)

تفاصيل العنوان

Fenofibrate Ameliorates Retinal Pigment Epithelium Injury Induced by Excessive Fat Through Upregulation of PI3K/AKT Signaling

• Authors : Wang X; Liu X; Tzekov R

Subjects: fenofibrate; rpe; palmitic acid (pa)

• Source: Drug Design, Development and Therapy, Vol Volume 17, Pp 3439-3452 (2023)

تفاصيل العنوان

Fenofibrate Ameliorates Oxidative Stress-Induced Retinal Microvascular Dysfunction in Diabetic Rats.

• Authors : Li J; a Department of Ophthalmology , Lishui Municipal Central Hospital, The Fifth Affiliated Hospital of Wenzhou Medical University , Lishui , PR China.; b Department of Ophthalmology , Lishui Hospital, Zhejiang University School of Medicine , Lishui , PR China.

Subjects: Diabetes Mellitus, Experimental/Diabetes Mellitus, Experimental/Diabetes Mellitus, Experimental/*drug therapy ; Diabetic Retinopathy/Diabetic Retinopathy/Diabetic Retinopathy/*drug therapy ; Fenofibrate/Fenofibrate/Fenofibrate/*pharmacology

• Source: Current eye research [Curr Eye Res] 2018 Nov; Vol. 43 (11), pp. 1395-1403. Date of Electronic Publication: 2018 Aug 17.Publisher: Informa Healthcare Country of Publication: England NLM ID: 8104312 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Fenofibrate ameliorates diabetic retinopathy by modulating Nrf2 signaling and NLRP3 inflammasome activation.

• Authors : Liu Q; Department of Ophthalmology, Affiliated Eye Hospital of Nanchang University, 463 Bayi Road, Nanchang, 330006, Jiangxi, China.; Zhang F

Subjects: Diabetic Retinopathy/Diabetic Retinopathy/Diabetic Retinopathy/*prevention & control ; Fenofibrate/Fenofibrate/Fenofibrate/*pharmacology ; Hypolipidemic Agents/Hypolipidemic Agents/Hypolipidemic Agents/*pharmacology

• Source: Molecular and cellular biochemistry [Mol Cell Biochem] 2018 Aug; Vol. 445 (1-2), pp. 105-115. Date of Electronic Publication: 2017 Dec 21.Publisher: Springer Country of Publication: Netherlands NLM ID: 0364456 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Protective effect of fenofibrate against high‐fat–high‐fructose diet induced non‐obese NAFLD in rats.

• Authors : Abdelmoneim, Doaa¹ (AUTHOR) ; El‐Adl, Mohamed¹ (AUTHOR); El‐Sayed, Gehad¹ (AUTHOR)

• Source: Fundamental & Clinical Pharmacology. Apr2021, Vol. 35 Issue 2, p379-388. 10p.

تفاصيل العنوان

Effect of switch to the highest dose of rosuvastatin versus add-on-statin fenofibrate versus add-on-statin nicotinic acid/laropiprant on oxidative stress markers in patients with mixed dyslipidemia.

• Authors : Kei A; Department of Internal Medicine, University of Ioannina Medical School, Ioannina, Greece.; Tellis C

Subjects: Dyslipidemias/Dyslipidemias/Dyslipidemias/*drug therapy ; Fenofibrate/Fenofibrate/Fenofibrate/*administration & dosage ; Fluorobenzenes/Fluorobenzenes/Fluorobenzenes/*administration & dosage

• Source: Cardiovascular therapeutics [Cardiovasc Ther] 2014 Aug; Vol. 32 (4), pp. 139-46.Publisher: Hindawi Country of Publication: England NLM ID: 101319630 Publication Model: Print Cited Medium: Internet ISSN: 1755-5922 (Electronic)

تفاصيل العنوان

Fenofibrate Therapy Restores Antioxidant Protection and Improves Myocardial Insulin Resistance in a Rat Model of Metabolic Syndrome and Myocardial Ischemia: The Role of Angiotensin II.

• Authors : Ibarra-Lara L; Department of Pharmacology, Juan Badiano 1, Sección XVI, Tlalpan, México City 14080, Mexico. .; Sánchez-Aguilar M

Subjects: Angiotensin II/Angiotensin II/Angiotensin II/*metabolism ; Antioxidants/Antioxidants/Antioxidants/*therapeutic use ; Fenofibrate/Fenofibrate/Fenofibrate/*therapeutic use

• Source: Molecules (Basel, Switzerland) [Molecules] 2016 Dec 28; Vol. 22 (1). Date of Electronic Publication: 2016 Dec 28.Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-3049

تفاصيل العنوان

Effect of Fenofibrate on the Expression of Inflammatory Mediators in a Diabetic Rat Model.

• Authors : Yeh, Po-Ting¹ (AUTHOR); Wang, Lu-Chun² (AUTHOR); Chang, Shu-Wen³ (AUTHOR)

• Source: Current Eye Research. Oct2019, Vol. 44 Issue 10, p1121-1132. 12p.

تفاصيل العنوان